By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
While Macy's Q1 beat expectations and raised FY26 guidance, the panelists express concerns about the decline in adjusted EBITDA and the sustainability of the 'Bold New Chapter' strategy. The key debate revolves around whether the EBITDA contraction is a temporary promotional spend or a sign of structural issues.
Risk: The decline in adjusted EBITDA and the potential for it to be a sign of structural issues rather than temporary promotional spend.
Opportunity: The potential for Bloomingdale's and Bluemercury to sustain top-line gains and drive operating leverage.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
(RTTNews) - Macy's, Inc. (M) revised its fiscal 2026 guidance, including raising net sales, comparable sales, and adjusted EPS guidance. Adjusted EPS is now expected in a range of $2.00 to $2.20, revised from prior guidance range of $1.90 to $2.10. Net sales are now expected in a range of $21.5 billion to $21.75 billion, updated from prior guidance range of $21.4 billion to $21.65 billion. Comparable sales change is now projected to be an increase in a range of 0.5% to 1.2%, compared to previous guidance of between a decline of 0.5% to an increase of 0.5%.
For the second quarter, the company projects: adjusted EPS in a range of $0.29 to $0.34; net sales of $4.75 to $4.80 billion; and comparable sales change in a range of flat to an increase of 1.0%.
First quarter GAAP net income was $63 million, compared to $38 million, a year ago. EPS was $0.23 compared to $0.13. Adjusted EBITDA was $290 million, compared to $304 million, last year. Adjusted EPS was $0.13, compared to $0.11.
First quarter net sales, inclusive of store closures, increased 1.8% to $4.7 billion, with comparable sales up 3.0%. Macy's, Inc. go-forward business comparable sales were up 3.1%. Comparable sales were positive at each of the nameplates. By nameplate: Macy's comparable sales were up 1.6%, inclusive of Reimagine 200 stores' comparable sales, up 2.4%; Bloomingdale's comparable sales were up 10.2%; and Bluemercury comparable sales were up 6.4%. Total revenue increased to $4.89 billion from $4.79 billion.
"We're off to a strong start to the year, exceeding expectations for the fifth consecutive quarter as our Bold New Chapter strategy continues to build momentum," said Tony Spring, chairman and CEO of Macy's, Inc.
The company ended the first quarter with cash and cash equivalents of $1.3 billion and had $2.0 billion of available borrowing capacity under its asset-based credit facility. As of the end of the first quarter, total debt was $2.4 billion. The company has no material long-term debt maturities until 2030.
In pre-market trading on NYSE, Macy's shares are up 2.51 percent to $22.23.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Macy's beat expectations but raised guidance modestly while EBITDA declined YoY, suggesting operational leverage is stalling despite comp sales growth."
Macy's beat Q1 expectations and raised FY26 guidance across all three metrics—a genuine positive. But the magnitude matters: EPS guidance lifted only $0.10 midpoint (2.6%), net sales $75M midpoint (0.3%), and comp sales moved from slightly negative to slightly positive. Bloomingdale's (+10.2%) and Bluemercury (+6.4%) are doing heavy lifting; Macy's nameplate comp sales of +1.6% is modest. Adjusted EBITDA actually declined YoY ($290M vs $304M), which contradicts the 'momentum' narrative. Debt remains substantial ($2.4B) against $1.3B cash. The 2030 debt maturity cliff is distant but real.
If consumer spending rolls over in H2 2024 or 2025, Macy's thin guidance raises (and reliance on luxury banners for growth) leave little margin for error—and the company's historical execution risk in turnarounds is well-documented.
"Macy's raise is real but modest and does not offset the year-over-year EBITDA decline or the sector's structural growth ceiling."
Macy's raised FY26 adjusted EPS guidance to $2.00-2.20 and comp sales to +0.5-1.2% after Q1 comps rose 3.0% and net sales hit $4.7 billion. Bloomingdale's and Bluemercury drove the beat while Macy's nameplate lagged at +1.6%. Yet adjusted EBITDA declined to $290 million from $304 million, and Q2 comp guidance is only flat to +1%. The $2.4 billion debt load remains manageable with no maturities until 2030 and $1.3 billion cash plus $2 billion credit line available. The 2.5% pre-market pop to $22.23 prices in early momentum from the Bold New Chapter plan, but department-store growth remains low-single-digit at best.
The guidance lift may simply correct overly cautious prior forecasts rather than signal accelerating demand, and the EBITDA drop already hints at margin pressure that could intensify if inventory or labor costs rise.
"The divergence between top-line growth and shrinking adjusted EBITDA indicates that Macy's is trading operational margin for revenue volume, creating a long-term sustainability risk."
Macy's Q1 performance reflects a successful tactical pivot, particularly within the Bloomingdale's and Bluemercury segments, which are clearly outpacing the core Macy's brand. Raising full-year guidance suggests management has visibility into inventory management and promotional discipline. However, the divergence between GAAP net income growth and a contraction in adjusted EBITDA—down to $290 million from $304 million—is a significant red flag. It suggests that while the top line is growing, operational efficiency is actually degrading. Investors are cheering the EPS beat, but the underlying cash flow generation is not keeping pace with the sales growth, signaling potential margin compression as the 'Bold New Chapter' strategy matures.
The contraction in adjusted EBITDA despite revenue growth suggests that the 'Bold New Chapter' strategy is structurally expensive and may be masking underlying cost inefficiencies with aggressive discounting.
"The raised FY26 guidance may be optimistic given potential margin compression and consumer-headwind risks, making the stock move a relief rally rather than a durable re-rating."
Macy's beat Q1 on comps and raised FY26 targets, signaling momentum from the Bold New Chapter. The upshift to net sales $21.5-$21.75B and adjusted EPS $2.00-$2.20, plus a Q2 guide, implies modest mid-single-digit top-line growth and a low-to-mid-single-digit earnings lift, aided by stronger nameplates (Bloomingdale's, Bluemercury) and favorable mix. Yet EBITDA declined y/y ($290M vs $304M), and the full-year guidance hinges on 0.5%-1.2% comps—risk that consumer strength falters or promo intensity rises. The article omits gross margin trajectory, capex plans, and cash flow durability, which are critical for sustaining earnings gains.
The upside could be a relief rally from beating estimates, not a durable earnings re-rate; if margin pressure or higher promo costs materialize, the 'raised' guidance may prove temporary.
"EBITDA decline may reflect deliberate promotional investment in a turnaround, not structural cost bloat—recovery trajectory matters more than one quarter's contraction."
Gemini flags the EBITDA contraction correctly, but all four of us are treating it as a margin-pressure signal without asking: what if it's temporary promotional spend to clear old inventory and establish the luxury positioning? Q1 comps of +3.0% on Macy's nameplate suggest the strategy is working tactically. The real test is whether EBITDA recovers in H2 as mix normalizes. We're conflating operational inefficiency with strategic investment—different animals.
"The EBITDA decline likely signals ongoing margin issues rather than one-time investment, given weak Q2 guidance."
Claude assumes the EBITDA drop is strategic investment, but the minimal Q2 comp guide of flat to +1% and continued EBITDA pressure risk suggest it's not temporary. With Macy's nameplate at just +1.6% and heavy debt, failure of the luxury mix shift to lift margins quickly could expose execution risks the guidance lift doesn't address.
"Macy's EBITDA contraction reflects structural cost-of-acquisition issues rather than temporary strategic investment."
Claude, you’re missing the structural reality: department stores don't have the luxury of 'strategic investment' periods when they are fighting a secular decline in mall traffic. The EBITDA contraction isn't just about clearing old inventory; it’s about the rising cost of customer acquisition in a saturated space. If the luxury shift at Bloomingdale's doesn't yield immediate operating leverage, Macy’s is just burning cash to buy temporary top-line relevance. This isn't a pivot; it's a defensive retreat.
"Gemini is too quick to call this a defensive retreat; the real test is whether Bloomingdale's and Bluemercury deliver immediate operating leverage, or else EBITDA softness plus debt and inventory costs could erode cash flow and make FY26 guidance fragile."
Gemini is too quick to call this a defensive retreat. If Bloomingdale's and Bluemercury sustain top-line gains, there is potential for operating leverage even amid EBITDA softness, especially with a more profitable mix and improved promo discipline. The real risk is whether the margin recovery can outpace debt and inventory costs; without that, the cash burn could widen, making the FY26 guidance fragile despite a Q1 beat.
While Macy's Q1 beat expectations and raised FY26 guidance, the panelists express concerns about the decline in adjusted EBITDA and the sustainability of the 'Bold New Chapter' strategy. The key debate revolves around whether the EBITDA contraction is a temporary promotional spend or a sign of structural issues.
The potential for Bloomingdale's and Bluemercury to sustain top-line gains and drive operating leverage.
The decline in adjusted EBITDA and the potential for it to be a sign of structural issues rather than temporary promotional spend.